Category: Pfizer

Some People More Prone to COVID-19 Vaccine Side Effects

Among individuals who have received COVID-19 vaccines, younger people, females, and those who got the second dose of the Moderna COVID-19 vaccine report more side effects from COVID-19 vaccines that may have led to moderate and severe limitations, according to a recent paper (Front Public Health 2022; doi: 10.3389/fpubh.2022.975781). These…

Continue Reading Some People More Prone to COVID-19 Vaccine Side Effects

Sickle Cell Disease Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

Sickle Cell Disease pipeline constitutes 40+ key companies continuously working towards developing 50+ Sickle Cell Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Sickle Cell Disease Overview Sickle Cell Disease is a group of inherited red blood cell disorders that…

Continue Reading Sickle Cell Disease Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

BBC’s jab travesty and the critics who will not be fobbed off

HAS the BBC’s complaints system finally come up against a foe that won’t be put off? A brief history of complaints about the travesty of a BBC documentary, Unvaccinated, proudly promoted in July, suggests it may well have.  The programme, presented by Professor Hannah Fry, signalled its bias from the start. Tom Coveney,…

Continue Reading BBC’s jab travesty and the critics who will not be fobbed off

RNA vaccines rose to prominence during COVID, but we’ve only scratched the surface of their potential

In high school biology, students are taught the central concept of genetics in a very simple way: DNA makes RNA, RNA makes protein, and protein makes life. In this way, RNA is central to everything in biology — and, you could argue, central to life itself. Biologically, DNA is the…

Continue Reading RNA vaccines rose to prominence during COVID, but we’ve only scratched the surface of their potential

Senior Associate Scientist, Bioinformatics at Pfizer in Pearl River, NY 10965

**Senior Associate Scientist, Bioinformatics -Viral Vaccines R&D** **Why Patients Need You** Pfizer’s purpose is to deliver breakthroughs that change patients’ lives. Research and Development is at the heart of fulfilling Pfizer’s purpose as we work to translate advanced science and technologies into the therapies and vaccines that matter most. Whether…

Continue Reading Senior Associate Scientist, Bioinformatics at Pfizer in Pearl River, NY 10965

Synthetic Biology Market Set for Rapid Growth 2031

Synthetic Biology Market Outlook 2031 The global synthetic biology market was valued at US$ 10.7 Bn in 2021 The global market is projected to advance at a CAGR of 21.3% from 2022 to 2031 The global synthetic biology market is anticipated to reach more than US$ 74.7 Bn by the end of 2031 Synthetic Biology Market Introduction Synthetic biology is a branch of science…

Continue Reading Synthetic Biology Market Set for Rapid Growth 2031

Bioinformatics Scientist, Statistical Inference #2568 at GRAIL

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale…

Continue Reading Bioinformatics Scientist, Statistical Inference #2568 at GRAIL

The Next Generation of COVID-19 Vaccines and Boosters

The US Food and Drug Administration (FDA) emergency use authorization (EUA) for the first vaccines combating COVID-19 was a milestone in the 2020 pandemic. Due to this provision, Pfizer-BioNTech’s BNT162b2 (Comirnaty), Moderna’s mRNA-1273 (Spikevax), and Johnson & Johnson/Janssen’s COVID-19 vaccine (Ad26.COV2.S) received EUAs for COVID-19 prevention in December 2020, February…

Continue Reading The Next Generation of COVID-19 Vaccines and Boosters

Restriction Endonucleases Products (REP) Market Business Overview and Global Development Trends

Global Restriction Endonucleases Products (REP) Market: Overview The leading applications for the products and solutions offered by the manufacturers and players functional in the landscape of the global restriction endonucleases products (REP) market include epigenetics, fragment length polymorphism or RFLP, cloning, sequencing, polymerase chain reaction, and restriction digestion, among others….

Continue Reading Restriction Endonucleases Products (REP) Market Business Overview and Global Development Trends

Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders

— Founded on the first and only platform designed to genetically engineer small molecule therapeutics from fungi and plants — — Led by veteran biotech executives Usman Azam, Chief Executive Officer, and Fred Grossman, Chief Medical Officer — NEW YORK & CAMBRIDGE, England, October 18, 2022–(BUSINESS WIRE)–Empyrean Neuroscience, Inc., a…

Continue Reading Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders

How new COVID-19 vaccines work

; DAY New vaccines against COVID-19 begin to be authorized around the world. How do they work, who makes them? Update on these new serums.  Adaptation to the evolution of viruses The virus of the disease COVID-19, SARS-CoV-2 , has the ability to mutate, like other viruses. It is a…

Continue Reading How new COVID-19 vaccines work

biomedical research: A database of 200 million-plus protein shapes is hypercharging biomedical research

On July 28, DeepMind, an artificial intelligence (AI) subsidiary of Alphabet, Google’s parent company, published a free, online database of the likely shapes of more than 200 million proteins known to science. This has set off a virtual carnival of biomedical research, which will transform healthcare as well as research…

Continue Reading biomedical research: A database of 200 million-plus protein shapes is hypercharging biomedical research

New Pre-Print Study Implies Airborne COVID-19 Antibodies Post-Vaccination

Since the rollout of mRNA COVID-19 vaccines, many researchers have speculated on the possibility of transmission of vaccine particles from the vaccinated to the unvaccinated, more commonly known as “vaccine shedding.” Though these speculations are routinely fact-checked, anecdotal stories of unvaccinated people who become infected with COVID-19 or have experienced…

Continue Reading New Pre-Print Study Implies Airborne COVID-19 Antibodies Post-Vaccination

Health System Warns Exemptions to COVID Vaccines May Expire With New Options

The Froedtert Health network in Wisconsin has sent a clear message to employees claiming religious exemptions from COVID-19 vaccination: with an alternative to mRNA vaccines now available, get vaccinated or resign. In an email to a Froedtert staff member obtained by WTMJ-TV, the health network’s COVID-19 Vaccine Religious Exemption Review…

Continue Reading Health System Warns Exemptions to COVID Vaccines May Expire With New Options

Lonza gains access to Touchlight’s enzymatic DNA technology

Under the terms of the agreement, Lonza can now provide its customers with seamless access to Touchlight’s enzymatic DNA technology. The Hampton, UK headquartered company said the synthetic DNA source enables GMP production at unprecedented speed, scale, and purity.   Both parties have agreed not to disclose financial or contractual terms…

Continue Reading Lonza gains access to Touchlight’s enzymatic DNA technology

NFT of mRNA vaccine research to go on sale

LONDON: A new NFT digital asset from the University of Pennsylvania showcases pivotal mRNA research that could lead to life-changing vaccines for COVID-19 and beyond. Dr. Drew Weissman, a physician and immunologist known for his groundbreaking contributions to RNA biology, and the RNA biochemist Dr. Katalin Kariko developed the modified…

Continue Reading NFT of mRNA vaccine research to go on sale

Injectable Drugs Market Analysis of the Competitive Landscape, with a Forecast for 2027

Wilmington, Delaware, United States, Transparency Market Research Inc. – The global injectable drugs market is relied upon to enlist a strong double-digit CAGR within the forecast period from 2019 to 2027. The market is majorly classified on the basis of drug-class, geography, molecule-type, and application. From the previous one entire…

Continue Reading Injectable Drugs Market Analysis of the Competitive Landscape, with a Forecast for 2027

Bioinformatics Software Engineer I – Genomics | Memorial Sloan Kettering Cancer Center

Nationwide, Company Overview At Memorial Sloan Kettering (MSK), we’re not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we’re driving excellence and improving outcomes. We’re treating cancer, one patient at a time….

Continue Reading Bioinformatics Software Engineer I – Genomics | Memorial Sloan Kettering Cancer Center

Efficient genome editing in wild strains of mice using the i-GONAD method

Mice A laboratory strain B6 was purchased from CLEA Japan Inc. (Tokyo, Japan), while nine wild strains (BFM/2, BLG2, CHD, HMI, KJR, MSM, NJL, PGN2, and SWN) were bred at NIG (Shizuoka, Japan) (Table 1). All mice were maintained at the animal facility in NIG, under specific-pathogen-free conditions and controlled…

Continue Reading Efficient genome editing in wild strains of mice using the i-GONAD method

Messenger DNA Vaccines For Pregnant Women Are Safe Against Kovid, According To A Study

Experts analyzed responses to questionnaires distributed to participants from seven Canadian provinces and territories Messenger DNA vaccines against COVID-19 such as Pfizer or Moderna are safe for pregnant women, according to a study published this Thursday. the Lancet, The research, by the Canadian Vaccine Safety Network (CANVAS), is one of…

Continue Reading Messenger DNA Vaccines For Pregnant Women Are Safe Against Kovid, According To A Study

Senior Associate Computational Toxicologist job with Pfizer

This position will be responsible for the continued development and maintenance of RNAseq data analysis and other bioinformatics pipelines. DSRD has invested heavily in our capacity to generate genomic and transcriptomic data, including quickly evolving areas such as single cell RNAseq and spatial transcriptomics. The successful candidate will be responsible…

Continue Reading Senior Associate Computational Toxicologist job with Pfizer

Relapsed/Refractory Anaplastic Large Cell Lymphoma

The term “relapsed” refers to disease that reappears or grows again after a period of remission. The term “refractory” is used to describe when the lymphoma does not respond to treatment (meaning that the cancer cells continue to grow) or when the response to treatment does not last very long….

Continue Reading Relapsed/Refractory Anaplastic Large Cell Lymphoma

A Novel COVID-19 Vaccine Using Modified Bacterial DNA

A visualization of the immune engineering process, from structure selection to authentic virus neutralization. Upper left: Analysis of interaction between SARS-CoV-2 and the ACE2 receptor revealed numerous contact residues along the receptor binding motif (RBM) ridgeline. Upper right: Focus was placed on residues comprising the FNCY patch, a conserved site…

Continue Reading A Novel COVID-19 Vaccine Using Modified Bacterial DNA

Omicron BA.5 sub-variant 4 times more vaccine-resistant, says study

The BA.5 Omicron subvariant, now the dominant coronavirus strain in the US, is four times more resistant to Covid-19 vaccines, according to a new study published in Nature. The study found the variant is four times more resistant to messenger RNA vaccines than earlier strains of Omicron, which include…

Continue Reading Omicron BA.5 sub-variant 4 times more vaccine-resistant, says study

Researchers Suspect New Variants of Rapidly-Progressing Brain Degenerating Diseases from COVID-19 Vaccines

Things have not been the same since June 2021 for 53-year-old Douglas Howey from Colorado. Around a year after he received the second dose of the Moderna COVID-19 vaccine, the 6 foot 4 and a half inch paraplegic man who once weighed 262 pounds lost over 100 pounds after the…

Continue Reading Researchers Suspect New Variants of Rapidly-Progressing Brain Degenerating Diseases from COVID-19 Vaccines

Front-Runners in the Race for Variant-Proof and All-Coronavirus Vaccines

SARS-CoV-2 – the coronavirus that causes Covid – is the third from its virus family to cause devastating pandemics or outbreaks in the last 20 years. First, there was the original SARS in 2002, and then MERS in 2012. As Fauci and others stress, even worse coronaviruses could spill over…

Continue Reading Front-Runners in the Race for Variant-Proof and All-Coronavirus Vaccines

Personalised cancer vaccine trials produce ‘really hopeful’ results | Science & Tech News

A personalised cancer vaccine made from individual patients’ own DNA has produced “really hopeful” early results. The ground-breaking jab, created using technology perfected in the COVID pandemic, is being given to patients after they complete conventional treatment for head and neck cancers. Patients have a high chance of the cancer…

Continue Reading Personalised cancer vaccine trials produce ‘really hopeful’ results | Science & Tech News

Bioinformatics Software Engineer III in New York, NY for Memorial Sloan-Kettering Cancer Center

Details Posted: 05-Jul-22 Location: New York, New York Type: Full-time Salary: Open Categories: Academic/Faculty Company Overview At Memorial Sloan Kettering (MSK), we’re not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we’re…

Continue Reading Bioinformatics Software Engineer III in New York, NY for Memorial Sloan-Kettering Cancer Center

Personalised cancer vaccine trials produce ‘really hopeful’ results

A personalised cancer vaccine made from individual patients’ own DNA has produced “really hopeful” early results. The ground-breaking jab, created using technology perfected in the COVID pandemic, is being given to patients after they complete conventional treatment for head and neck cancers. Patients have a high chance of the cancer…

Continue Reading Personalised cancer vaccine trials produce ‘really hopeful’ results

Beam Therapeutics Stock: A Leader in Gene Editing Tech?

Don’t invest in stories. Don’t invest in a company before they have meaningful revenues. Don’t invest in drug developers that have a great deal of regulatory risk. These are all rules we need to break if we want exposure to a technology that allows mankind to start playing with the…

Continue Reading Beam Therapeutics Stock: A Leader in Gene Editing Tech?

Biotechnology Careers

Images for Biotechnology Careers Biotechnology Careers: In-Demand Jobs Shaping Our Future ICAR-NRCB Recruitment 2020 – BSc Microbiology & Biotechnology Job Govt RGCB Research Jobs – Biotechnology & Bioinformatics JRF Position Biotech Jobs | CT19 Biotechnology Job Outlook | A Career in High Demand 9 of the Best Biotechnology Careers For…

Continue Reading Biotechnology Careers

FDA Flags Heart Inflammation Risk Over Novavax COVID-19 Vaccine

Staff with the U.S. Food and Drug Administration (FDA) on Friday flagged the risk of heart inflammation following the administration of the Novavax COVID-19 vaccine, although they concluded the shot reduces the risk of mild-to-severe COVID-19. In the company’s nearly 30,000 patient trial, conducted between December 2020 and September 2021, there…

Continue Reading FDA Flags Heart Inflammation Risk Over Novavax COVID-19 Vaccine

Restriction Endonucleases Products (REP) Market: Overview, Major Trends & Regional Assessment

Global Restriction Endonucleases Products (REP) Market: Overview Albany NY, United States: The leading applications for the products and solutions offered by the manufacturers and players functional in the landscape of the global restriction endonucleases products market include epigenetics, fragment length polymorphism or RFLP, cloning, sequencing, polymerase chain reaction, and restriction…

Continue Reading Restriction Endonucleases Products (REP) Market: Overview, Major Trends & Regional Assessment